Skip to main content
. 2019 Jun;8(3):273–282. doi: 10.21037/tau.2019.06.02

Table 2. Summary of FtM IPP studies: device survival and satisfaction.

Study Original device survival [N] Patient with penetrative intercourse
Leriche [2008] 51%
Hoebeke [2010] 58.9% [76]
Zuckerman [2015] 81%
Neuville [2016] 62.3% [43]
Falcone [2018] 56.6% [140] 77%
Cohen [2017] 30% [3]